Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The FDA is seeking qualified vendors for the SIRCE II initiative, focusing on IT modernization and support services. This RFI aims to gather information on industry capabilities and innovative solutions. Amendments have adjusted page limits and clarified response requirements. Interested parties should respond accordingly.
The purpose of Amendment 03 is to increase the page limit to 10 pages. The purpose of Amendment 02 is to remove this statement formerly located in the last paragraph, " Please note that a respondents failure to provide a complete response to the information requested in this Section 7, will be interpreted to mean that it does not understand what information is being requested and does not demonstrate the capability to provide services required." The purpose of Amendment 01 is to correct the estimated ceiling from $400,000,000 to $300,000,000. The U.S. Food and Drug Administration (FDA) is conducting market research to identify qualified vendors capable of supporting the OII Systems for Inspection & Imports, Recalls Compliance, and Enforcement (SIRCE) II initiative. This Request for Information (RFI) is issued solely for market research purposes to assess industry capabilities, capacity, and innovative approaches for delivering comprehensive IT modernization and support services.
SIRCE II is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.